Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromatin is the complex of DNA and associated proteins, primarily histones, that organizes the eukaryotic genome within the cell nucleus (National Human Genome Research Institute). Its primary biological function is to package long DNA molecules into compact structures, protecting the genetic code and regulating access for vital processes such as replication, transcription, and repair (Nature Reviews Molecular Cell Biology). In many diseases, particularly oncology, the structural integrity and epigenetic state of chromatin are frequently dysregulated, contributing to uncontrolled cell proliferation and genomic instability (Nature Reviews Cancer). This target complex is the focus of numerous therapeutic interventions; for example, cytotoxic chemotherapies like platinum-based agents and alkylators bind directly to DNA, while other agents target the proteins that manage DNA topology or histone modifications (NIH/NCI Dictionary of Cancer Terms). Because these structures are fundamental to the survival of all dividing cells, therapeutic targeting often involves a narrow therapeutic window and significant safety concerns, including myelosuppression and the risk of secondary cancers (American Cancer Society).
Drugs targeting this complex function through DNA alkylation and cross-linking, intercalation between base pairs to disrupt replication, inhibition of topoisomerase enzymes to induce double-strand breaks, or modulation of histone-modifying enzymes to alter the epigenetic state of the genome (StatPearls, 'Chemotherapy Mechanism of Action', 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromatin (DNA and associated proteins).